These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 25043465)

  • 1. Cost-effectiveness analysis of new drugs for chronic hepatitis C: the importance of updating utility values.
    Cortesi PA; Scalone L; Mantovani LG
    Hepatology; 2015 Mar; 61(3):1096-7. PubMed ID: 25043465
    [No Abstract]   [Full Text] [Related]  

  • 2. A cure for the high cost of hepatitis C virus treatment.
    Etzion O; Ghany MG
    Ann Intern Med; 2015 May; 162(9):660-1. PubMed ID: 25820765
    [No Abstract]   [Full Text] [Related]  

  • 3. The high price of the new hepatitis C virus drugs.
    Steinbrook R; Redberg RF
    JAMA Intern Med; 2014 Jul; 174(7):1172. PubMed ID: 24798183
    [No Abstract]   [Full Text] [Related]  

  • 4. The comparative clinical effectiveness and value of simeprevir and sofosbuvir for chronic hepatitis C virus infection.
    Ollendorf DA; Tice JA; Pearson SD
    JAMA Intern Med; 2014 Jul; 174(7):1170-1. PubMed ID: 24798321
    [No Abstract]   [Full Text] [Related]  

  • 5. Sovaldi ushers in wave of costly hepatitis C drugs.
    Manag Care; 2014 Jan; 23(1):51. PubMed ID: 24765752
    [No Abstract]   [Full Text] [Related]  

  • 6. Reply: To PMID 24691835.
    Petta S; Cabibbo G; Cammà C
    Hepatology; 2015 Mar; 61(3):1097. PubMed ID: 25043351
    [No Abstract]   [Full Text] [Related]  

  • 7. [Chronic hepatitis C. Something new].
    Sabourin G
    Perspect Infirm; 2015; 12(1):60. PubMed ID: 25651685
    [No Abstract]   [Full Text] [Related]  

  • 8. Special report: cost-effectiveness studies of new hepatitis C treatments.
    Mark DH;
    Technol Eval Cent Assess Program Exec Summ; 2015 Jan; 29(10):1-3. PubMed ID: 25962188
    [No Abstract]   [Full Text] [Related]  

  • 9. Hepatitis C Virus Infection Is Systemic: Meeting Additional Goals.
    Modi R; Saab S
    J Infect Dis; 2015 Aug; 212(3):343-4. PubMed ID: 25583165
    [No Abstract]   [Full Text] [Related]  

  • 10. Hepatitis C genotype 3: a tough match for interferon-free regimens.
    Aghemo A; Colombo M
    Gastroenterology; 2014 Apr; 146(4):1125-7. PubMed ID: 24566101
    [No Abstract]   [Full Text] [Related]  

  • 11. [A new era in therapy of chronic hepatitis C].
    Füessl HS
    MMW Fortschr Med; 2015 Feb; 157(2):38. PubMed ID: 25743515
    [No Abstract]   [Full Text] [Related]  

  • 12. Combination of daclatasvir and sofosbuvir for hepatitis C genotypes 1, 2, and 3.
    Bari K; Sharma P
    Gastroenterology; 2014 Aug; 147(2):534-6. PubMed ID: 24953626
    [No Abstract]   [Full Text] [Related]  

  • 13. Therapy for hepatitis C--the costs of success.
    Hoofnagle JH; Sherker AH
    N Engl J Med; 2014 Apr; 370(16):1552-3. PubMed ID: 24725236
    [No Abstract]   [Full Text] [Related]  

  • 14. [Not Available].
    Pariente A
    Rev Prat; 2015 Jan; 65(1):29. PubMed ID: 25842421
    [No Abstract]   [Full Text] [Related]  

  • 15. Sofosbuvir for previously untreated chronic hepatitis C infection.
    Lawitz E; Gane EJ
    N Engl J Med; 2013 Aug; 369(7):678-9. PubMed ID: 23944316
    [No Abstract]   [Full Text] [Related]  

  • 16. Sofosbuvir for previously untreated chronic hepatitis C infection.
    Hsu CS
    N Engl J Med; 2013 Aug; 369(7):678. PubMed ID: 23944317
    [No Abstract]   [Full Text] [Related]  

  • 17. [Sofosbuvir: alternative in hepatitis C infection?].
    Blum HE
    Dtsch Med Wochenschr; 2013 Aug; 138(33):1646-7. PubMed ID: 23913349
    [No Abstract]   [Full Text] [Related]  

  • 18. FDA perspective on sofosbuvir therapy for patients with chronic hepatitis C virus genotype 1 infection who did not respond to treatment with pegylated interferon and ribavirin.
    Mishra P; Florian J; Qi K; Zeng W; Naeger LK; Donaldson E; Connelly S; O'Rear J; Price D; Murray J; Birnkrant D
    Gastroenterology; 2014 Dec; 147(6):1196-200. PubMed ID: 25449024
    [No Abstract]   [Full Text] [Related]  

  • 19. [Begin of a new era in treating hepatitis C in Patients on the waiting list and after liver transplantation].
    Beckebaum SK; Schmidt HH
    Z Gastroenterol; 2014 Jul; 52(7):746-8. PubMed ID: 25026012
    [No Abstract]   [Full Text] [Related]  

  • 20. [Sofosbuvir for hepatitis C - is brevity the soul of wit?].
    Zimmermann HW; Tacke F
    Z Gastroenterol; 2013 Sep; 51(9):1110-2. PubMed ID: 24022206
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.